Location History:
- Oslo, NO (2020)
- Tromso, NO (2017 - 2021)
Company Filing History:
Years Active: 2017-2021
Title: The Innovative Contributions of Tore Seternes
Introduction
Tore Seternes is a notable inventor based in Tromso, Norway. He has made significant contributions to the field of pharmaceuticals, particularly in the development of oral drug delivery systems. With a total of 3 patents to his name, Seternes continues to push the boundaries of innovation in his field.
Latest Patents
Seternes' latest patents include groundbreaking inventions such as "Oral pharmaceutical dispersion compositions." This invention provides an oral pharmaceutical composition, optionally in dose unit form, comprising a lipophilic drug substance in dispersion in a physiologically tolerable aqueous carrier, preferably an aqueous gel. The drug substance contains a functional electrostatic group having a pKa value of from 2 to 10, characterized in that the aqueous carrier has a pH at least 0.3 below or above the pKa value. This pH is below the pKa where the group is acidic and above the pKa where the group is basic. Another notable patent is "Chewable gelled emulsions," which describes an oral pharmaceutical composition in unit dose form. Each unit dose comprises a lipophilic drug substance within a unitary carrier body, which consists of a soft, chewable, gelled oil-in-water emulsion.
Career Highlights
Throughout his career, Seternes has worked with various companies, including Vitux Group AS and Ayanda Group AS. His work has focused on enhancing the effectiveness of drug formulations, making them more accessible and easier to consume for patients.
Collaborations
Seternes has collaborated with notable individuals in his field, including Kurt Ingar Draget and Ingvild Johanne Haug. These collaborations have contributed to the advancement of his innovative projects and patents.
Conclusion
Tore Seternes is a prominent figure in the pharmaceutical industry, known for his innovative patents and contributions to drug delivery systems. His work continues to impact the field positively, paving the way for future advancements in oral pharmaceutical compositions.